Please login to the form below
patient data
This page shows the latest patient data news and features for those working in and with pharma, biotech and healthcare.
Takeda and Daiichi Sankyo collaborate to create wearable device
model case for the collection and use of diverse data under appropriate processes.”. ... Ceri Davies, head of Takeda’s neuroscience drug discovery unit, said: “The digitisation and visualisation of individual lifestyle data will dramatically
Latest news
-
AstraZeneca’s Imfinzi plus chemotherapy accepted for Priority Review in the US
Data taken from the TOPAZ-1 phase 3 trial demonstrated Imfinzi plus chemotherapy (gemcitabine plus cisplatin) reduced the risk of death by 20% compared to the use of chemotherapy alone. ... There was a significant 25% reduction in the risk of disease
-
Sanofi’s Rezurock results show positive patient outcomes
Following the studies, the data also supports the use of PROs for response assessment in cGVHD clinical trials and patient care in order to help capture the pivotal individual perspectives on ... Jonathan Ieyoub, head of Sanofi US Rezurock Medical, was
-
Sanofi and Exscientia agree on a deal worth up to $5.2bn for AI-driven therapies
The platform itself adopts a ‘patient-first’ approach by assimilating primary human tissue samples into early target and drug research. ... By using this approach, Exscientia scientists are able to promote patient-centricity earlier in the drug
-
FDA approves Eli Lilly’s Verzenio in high risk early breast cancer
Verzenio is the first and only CDK4/6 inhibitor approved for this patient population. ... Data supporting this approval will be presented at the European Society for Medical Oncology (ESMO).
-
Mixed results for AC Immune's promising Alzheimer’s antibody
Safety data showed that semorinemab is well tolerated with an acceptable safety profile. ... s. Rachelle Doody, global head of neurodegeneration at partner Roche, agreed that the data represented a positive step forward.
More from news
Approximately 9 fully matching, plus 334 partially matching documents found.
Latest Intelligence
-
The decentralisation of clinical trials is a key catalyst for innovation in artificial intelligence
We are seeing a rapid expansion in the use of mobile and patient-centric devices, exponential growth in the volume and diversity of life sciences data and acceleration in the use ... More data means more opportunity to develop smart risk monitoring
-
Listen, learn and lift off
remains. Yet, anxiety swirls around strategising commercial drug launches through harnessing patient insights and data, identifying client segments, timings and the new generation of omnichannel options. ... Grimes- Crompton, senior adviser at healthtech
-
Mapping patient pathways – with a focus on patient-centricity
As healthcare professionals (HCPs) look to translate patient data – from time to diagnosis and treatment through to treatment measures – into day-to-day patient-centric pathways, it’s essential that the ... The findings are drawn from a small
-
Decentralised clinical trials: mapping patient pathways with a focus on patient-centricity
decentralised clinical trials to optimise efficiencies while obtaining quality data and giving patients convenient access to care. ... The focus needs to be on smart solutions that bring research to the patient, manage patient safety, streamline data
-
Charting patient pathways with precision for better healthcare
way, then we can start to build pathways that are more patient-centric. ... VISFO specialises in generating insights from granular patient data and experiences to transform care and Williams believes examining every aspect of patient experience can
More from intelligence
Approximately 0 fully matching, plus 122 partially matching documents found.
Latest appointments
-
VMLY&Rx launches new payer agency in the US
She later transitioned into the agency setting with a focus on HCP, patient marketing, data analytics, behavioural science and health economics. ... The VMLY&Rx Payer team will aim to provide strategic support to clients in the US working across the
-
Syneos Health appoints Tim Pantello as president of communications
Prior to Syneos Health, Pantello was a managing director at PricewaterhouseCoopers (PwC), leading multiple offerings within the Health Industry Advisory Group related to wearable data, patient intelligence and predictive behaviours and
-
Christie Anbar appointed global healthcare lead at Ruder Finn
In her new role, Anbar will lead the company’s partnership with clients ranging from major biopharmaceutical companies to emerging biotech, tech and health data pioneers, as well as patient advocacy ... cutting-edge solutions and remaining ahead of
-
Exco InTouch appoints president and COO
Steve Powell will lead the mobile healthcare app and data capture firm. ... He brings 25 years of healthcare technology experience to Exco InTouch, with a focus on operational and technology growth in clinical research organisations and biotechs, as well
-
PatientsLikeMe names Jason Johnson as head of R&D
Johnson will lead the company's research, data science and informatics teams, which focus on analysing and merging patient-reported data and other data types to develop models of disease progression ... Martin Coulter, CEO at PatientsLikeMe, said: “Our
More from appointments
Approximately 0 fully matching, plus 7 partially matching documents found.
Latest from PMHub
-
Virtual MSL/Sales training programs and events
and real-world data, as well as patient lifestyle management strategies.
-
Using ethnography to uncover the authentic patient experience
What’s more, a number of the regulatory bodies now require companies to collect patient experience data to ensure that drug development is patient-focused and meeting the needs of the ... UK are now requiring that companies collect patient experience
-
What does the future hold for clinical trial recruitment?
Calculating how many patients are needed to give your data clinical relevance is a science in itself. ... Worries over data privacy also exacerbate this. Which means communicating what will happen with patient data – in a friendly and clear way – is
-
From Vision to Action: Medical Affairs’ Time to Lead is Now – Key Themes and Takeaways From the 2022 Medical Affairs Professional Society (MAPS) Global Annual Meeting
HCP notes and patient registries are data sources that would facilitate this, but there is scrutiny of registries by the FDA, which poses a challenge. ... It was noted that the FDA now expects the patient voice to be incorporated into trial data,
-
Envision Pharma Group and Vitaccess create a global partnership to power evidence generation for the biopharmaceutical industry
Acknowledging that every client need is unique, this collaboration will help leverage patient-centric digital solutions to gather data quickly, flexibly, and at scale, and incorporate patients’ “lived experience” – insights which ... We are
More from PMHub
Approximately 9 fully matching, plus 118 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Bristol Myers Squibb announces positive trial results for treatment of MS
- Biogen and Happify Health team up to create digital platform for MS patients
- Moderna to launch Innovation and Technology Center in the UK
- Enanta takes legal action against Pfizer over Paxlovid patent infringement
- Novartis and Precision BioSciences announce in vivo gene editing collaboration
- Pfizer and BioNTech share positive results for Omicron-adapted COVID-19 vaccine
- Live Webinar: Navigating the Nuances of Europe's MedTech Industry
- Why project managers are key to creating quality content
- Pfizer and BioNTech sign $3.2bn COVID-19 vaccine supply agreement with US government
- EMA grants Bavarian Nordic access to PRIME scheme for RSV vaccine candidate
- Eli Lilly to supply US government with 150,000 additional doses of bebtelovimab
- NICE issues final appraisal recommending LEO Pharma’s Adtralza for moderate-to-severe atopic dermatitis
- ALL SYSTEMS GO: UNDERSTANDING WHO’S WHO IN THE NEW NHS LANDSCAPE
- A creative awakening – how pharma is bringing innovation to the patient journey
- AstraZeneca’s Evusheld phase 3 results show high level of protection against COVID-19
- Eli Lilly to supply US government with 150,000 additional doses of bebtelovimab
- EMA grants Bavarian Nordic access to PRIME scheme for RSV vaccine candidate
- Innovative Health Initiative launches first two calls for proposals to tackle ‘biggest’ health research challenges
PMHub
Research Partnership
Research Partnership is now a member of Inizio Advisory, the consulting business unit of Inizio, a strategic partner for health...
Latest intelligence
- Our Top 5 Pharma Picks From Cannes Lions
- Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
- The Evolving Role of the Sales Rep
- The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
- Measure your omnichannel maturity with our new tool
- Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
